Our study explores the relationship between RBM10 and pancreatic cancer immunity, showing that RBM10 loss may influence PD-1 expression in NK cells through the JAK-STAT pathway, potentially contributing to tumour immune escape. Here, SOAT1 is linked to pancreatic neoplasm.